SMALL GRANT PROGRAM FOR CONFERENCE SUPPORT

在过去的几年里，很明显，当代医学的大多数实践都依赖于经验，权威或习惯，而不是这些实践可以改善患者健康的客观证据[1]。 因此，循证医学运动诞生了，试图通过对现有证据的系统标准化分析来“找出医学中什么有效，什么无效”[2]。 了解我们的诊断和治疗干预措施的质量的重要性已被评估“.作为一个企业，竞争对手的人类基因组计划在其潜在的影响，现代医学”[2]。在肿瘤学现有证据质量的系统分析方面，工作做得很少。因此，我们建议组织一次题为“循证肿瘤学实践”的会议来解决这个问题，并探讨确定哪些干预措施有效，哪些干预措施无效的过程。 会议将有两个目标：1）提供最常见癌症条件下现有证据的优势和弱点的理解，2）教授收集和批判性评估证据的过程。为了实现这些目标，将采用三种教育形式：1）讲座式教学会议，随后是“问答”讨论，其中著名的卫生保健专业人员将专注于对有关特定恶性疾病管理的证据进行标准化分析，2）研讨会“如何实践循证肿瘤学”，其中参与者将学习a）如何将信息需求转化为临床可回答的问题，B）如何追踪回答临床问题的最佳证据，c）如何批判性地评估证据的有效性（接近真相）、重要性（效应大小）和有用性（临床适用性），d）如何将评估与临床专业知识相结合，并将结果应用于临床实践，以及3）关于医学证据在管理-护理决策中的作用的小组讨论。在本次会议结束时，所有与会者应该能够：理解证据的科学分析的性质，并讨论恶性疾病管理的循证建议的类型和质量。

Over the last several years it has become apparent that most practices in contemporary medicine rest on the experiences, authority or habits rather than on objective evidence that these practices can improve patients' health [1]. As a result, the evidence-based medicine movement was born attempting to "find out what works and what doesn't in medicine" through systematic standardized analyses of available evidence [2]. Importance of understanding the quality of our diagnostic and treatment interventions has been assessed "...as an enterprise that rivals the Human Genome Project in its potential implications for modern medicine" [2]. Very little work has been done on systematic analysis of the quality of available evidence in oncology. Therefore, we propose to organize a conference titled "Evidence-based Practice of Oncology" to address this issue and to explore the process for determining which interventions work and which interventions do not in the management of various oncological disorders. The conference will have two goals: 1) to provide understanding strength and weaknesses of available evidence in the most common cancer conditions, 2) to teach the process of gathering and critical appraisal of evidence. To accomplish these goals, three educational formats will be used: 1) lecture-type didactic sessions followed by "questions and answer" discussions in which prominent health care professionals will focus on standardized analysis of evidence regarding management of specific malignant disorders, 2) workshop "How to practice evidence-based oncology" in which participants will learn a) how to convert information needs into clinically answerable question, b) how to track down the best evidence with which to answer a clinical question, c) how to critically appraise that evidence for its validity (closeness to the truth), importance (size of effect) and usefulness (clinical applicability), d) how to integrate the appraisal with clinical expertise and apply the results in clinical practice, and 3) panel discussion on the role of medical evidence in manage-care decisions. At the conclusion of this conference, all participants should be able to: understand the nature of scientific analysis of evidence and to discuss a type and quality of evidence-based recommendations for the management of malignant disorders.